Skip to main content
. 2019 Mar 31;20(7):1007–1016. doi: 10.1080/15384047.2019.1595276

Figure 1.

Figure 1.

Upregulation of FOXD2-AS1 predicted poor prognosis for HCC patients. A. Based on the TCGA data, high expression of FOXD2-AS1 was closely correlated with the poor prognosis of HCC patients. B. The expression of FOXD2-AS1 was examined in 88 pairs of HCC tissues and adjacent non-malignant tissues. C. Kaplan Meier method was used to analyze the relevance between FOXD2-AS1 expression and overall survival rate of HCC patients. *P < 0.05, **P < 0.01 vs control group.